|
Get Full Access To This Report | or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
Phenomenex Inc
Business Summary
Phenomenex Inc is a privately-held company that provides analytical chemistry solutions to solve the separation and purification challenges in industrial, clinical, government and academic research. Phenomenex Inc was founded in 1982. Phenomenex headquarters is located in Torrance, California.
Overview & Corporate Organization
Basic Information
| Year Founded: | 1982 |
| Formerly Named: | Fasha Mahjoor |
| Fiscal Year End: | 12/31 |
| 1YR Revenue Growth Rate: | View % |
| 3YR Revenue Growth Rate (CAGR): | View % |
| 1YR Employee Growth Rate: | View % |
| 3YR Employee Growth Rate (CAGR): | View % |
| City: | Torrance |
| State/Province: | California |
| Country: | United States |
| Phone: | View |
| Fax: | View |
| Website: | www.phenomenex.com |
Corporate Organization
| Subsidiaries: |
Industry Information
PrivCo Industries (Sector > Industry > Sub-Industry)
| Healthcare > Pharmaceuticals > Pharmaceutical Research & Drug Discovery |
| Services > Architectural, Engineering, & Surveying Services > Chemical Engineering Services |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Competitors & Comparables
Competitors
| Agilent Technologies, Inc. |
| ASAP Analytical |
| ChromaDex Corp |
| chromtech |
| Labhut |
| MicroSolv |
| PerkinElmer, Inc. |
| Qmx Laboratories |
| Restek |
| Sigma-Aldirch |
| teknolab |
| Waters Corporation |
Charts, Financials, and Statistics (Table Format)
Copy & Paste Financials Into Spreadsheet or
| Financial Notes: | |
| * | Phenomenex Inc fiscal year end: 12/31 |
Charts, Financials, and Statistics (Graphs)
(Copy and paste into spreadsheet or export all Phenomenex Inc financials to Excel and create your own graphs.)
To view the graphs below, unlock this company report for $99 or Upgrade to a PrivCo Premium Subscription for site-wide access to all PrivCo private company research reports.
Phenomenex Inc Revenues ($ MM): |
Phenomenex Inc Total Employees: |
Phenomenex Inc Productivity (Revenue/Employee) ($): |
Mergers & Acquisitions
| Date | Status | Target | Buyer | Deal Type | Price | |
| Details | Apr. 2007 | Completed | View | View | Acquisition | View |
| Details | Apr. 2007 | Completed | View | View | Acquisition | View |
| Details | Aug. 2012 | Completed | View1 | View | Acquisition | View |
| 1 | Phenova,...Read More → |
Full-length notes are available with Single Report Access or PrivCo Premium Subscription. |
Missing a deal? Tell us about it! tips@privco.com
Detailed Business Description: Phenomenex Inc
Phenomenex Corporate Overview
Business Description:
Phenomenex Inc designs and manufacturers products used in the field of separation, analysis and purification of chemicals and biochemicals, with a focus on sample preparation, high-performance liquid chromatography (HPLC) and gas chromatography (GC).
Phenomenex products include: EZfaast, a kit that is used for Amino Acid Analysis; iMethod, a test for food safety testing; Zebron, a GC column; HPLC/UHPLC solutions; Oligonucleotide, a separation solution; Axia, a preparative column; Strata, a silica-based SPE sorbent; Impact, a protein precipitation plate; Phenex, a syringe filter; vials; super critical fluid chromatography solutions; Strata-X, a polymeric SPE sorbent.
Phenomenex Revenue Model:
Phenomenex generates revenue primarily through the manufacturing and sale of analytical laboratory equipment which separate chemical and biochemical solutions using techniques such as HPLC, GC, amino-acid analysis, Oligonucleotide… Continue Reading →
Supplemental Resources
|
Get Full Access To This Report | or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |







